A California jury awarded $332 million* this week to a consumer who sued chemical giant Monsanto, contending that his cancer was related to decades of using its Roundup weedkiller. The man was diagnosed in 2020 with a rare form of non-Hodgkin’s lymphoma; there is no cure for his illness. His lawsuit contended that his illness was related to Roundup’s active ingredient, glyphosate.
The jury found that Monsanto, which is now a division of pharmaceutical and biotechnology giant Bayer**, failed to provide warnings of Roundup’s risks.
–
*A total of $7 million was awarded in compensatory damages and $325 million in punitive damages.
.
**Bayer bought Monsanto for $63 billion in 2018 and has been trying to deal with thousands of claims and lawsuits related to Roundup. In 2020, Bayer announced it would pay up to $10.9 billion to settle some 125,000 filed and unfiled claims.
Source: AP
Eric
